12:00 AM
 | 
Aug 27, 2012
 |  BC Week In Review  |  Company News  |  Other News

Scancell cancer news

Scancell unveiled its Moditope vaccine technology that stimulates the production of killer CD4 T cells against cancer. The company said its board is evaluating strategic options for the technology. Scancell added that the Moditope epitopes can be used to develop DNA...

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >